Share It

Top Menu

Wednesday, June 6, 2012

Biosimilars have provided many challenges and opportunities in equal measure for innovators and applicants. Biosimilars-2012 is designed to discuss the development and progress of research in the areas of drug discovery, clinical trials, regulatory and economic considerations towards Biosimilars and Biowaivers.